CA2684552A1 - Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds - Google Patents

Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds Download PDF

Info

Publication number
CA2684552A1
CA2684552A1 CA002684552A CA2684552A CA2684552A1 CA 2684552 A1 CA2684552 A1 CA 2684552A1 CA 002684552 A CA002684552 A CA 002684552A CA 2684552 A CA2684552 A CA 2684552A CA 2684552 A1 CA2684552 A1 CA 2684552A1
Authority
CA
Canada
Prior art keywords
hydroxyphenyl
indolin
compound
optionally substituted
difluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002684552A
Other languages
English (en)
French (fr)
Inventor
Mette Knak Christensen
Fredrik Bjoerkling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onxeo DK
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2684552A1 publication Critical patent/CA2684552A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002684552A 2007-04-24 2008-04-24 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds Abandoned CA2684552A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91362507P 2007-04-24 2007-04-24
US60/913,625 2007-04-24
PCT/EP2008/054990 WO2008129075A1 (en) 2007-04-24 2008-04-24 Substituted 3-(4-hydroxyphenyl)-indolin-2-one-compounds

Publications (1)

Publication Number Publication Date
CA2684552A1 true CA2684552A1 (en) 2008-10-30

Family

ID=39643405

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002684552A Abandoned CA2684552A1 (en) 2007-04-24 2008-04-24 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds

Country Status (6)

Country Link
US (1) US20100227863A1 (OSRAM)
EP (1) EP2139856A1 (OSRAM)
JP (1) JP2010525024A (OSRAM)
AU (1) AU2008240599A1 (OSRAM)
CA (1) CA2684552A1 (OSRAM)
WO (1) WO2008129075A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718611A4 (en) 2004-02-13 2009-09-23 Harvard College 3-3-DI-SUBSTITUTED OXINDOLES AS INHIBITORS OF INITIATION OF TRANSLATION
WO2010109008A1 (en) 2009-03-26 2010-09-30 Topotarget A/S Prodrugs of substituted 3-(4-hydroxyphenyl)-indolin-2-ones
US20160106711A1 (en) * 2012-09-20 2016-04-21 President And Fellows Of Harvard College 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
CN105017129B (zh) * 2015-07-02 2017-12-26 广东药科大学 一种吲哚生物碱及其应用
CN110526853B (zh) * 2018-05-23 2021-02-26 浙江大学 3,3-二取代-2-吲哚酮衍生物及其制备方法
CA3103958A1 (en) * 2018-07-03 2020-01-09 The Board Of Trustees Of The University Of Illinois Activators of the unfolded protein response
EP3912625A1 (en) * 2020-05-20 2021-11-24 Kaerus Bioscience Limited Novel maxi-k potassium channel openers for the treatment of fragile x associated disorders
CA3196210A1 (en) * 2020-10-23 2022-04-28 The Board Of Trustees Of The University Of Illinois Anticancer compounds selective for er-positive cancers
CN113149888B (zh) * 2021-05-06 2023-03-03 中山大学 一种羟基吲哚酮类衍生物及其制备方法和应用
CN115490673B (zh) * 2022-01-11 2024-10-15 苏州浦合医药科技有限公司 3,3-二取代吲哚酮类化合物及其用途
CN120677152A (zh) * 2023-02-23 2025-09-19 上海济煜医药科技有限公司 双环类化合物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718611A4 (en) * 2004-02-13 2009-09-23 Harvard College 3-3-DI-SUBSTITUTED OXINDOLES AS INHIBITORS OF INITIATION OF TRANSLATION
US20070299102A1 (en) * 2004-04-08 2007-12-27 Topo Target A/S Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer

Also Published As

Publication number Publication date
EP2139856A1 (en) 2010-01-06
AU2008240599A1 (en) 2008-10-30
WO2008129075A1 (en) 2008-10-30
JP2010525024A (ja) 2010-07-22
US20100227863A1 (en) 2010-09-09

Similar Documents

Publication Publication Date Title
CA2684552A1 (en) Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds
CA2883545C (en) Imidazoline derivatives, preparation methods thereof, and their applications in medicine
EP2592081B1 (en) Tetrahydrocarboline derivative
CN108366996A (zh) 四氢-1H-吡啶[3,4-b]吲哚类抗雌激素药物
RS59474B1 (sr) Heteroarilna jedinjenja koja su korisna kao inhibitori sumo-aktivirajućeg enzima
WO2016131381A1 (en) Fused-ring compounds, pharmaceutical composition and uses thereof
CA2705833A1 (en) 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
CN105481789A (zh) 一种吲哚胺-2,3-双加氧酶抑制剂及其制备方法
WO2010114881A1 (en) Anti-neoplastic compounds, compositions and methods
EA028175B1 (ru) Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания
JP2021526560A (ja) カンプトテシン誘導体およびその調製方法並びに用途
EP3943083A1 (en) Small-molecule inhibitor of pd-1/pd-l1, pharmaceutical composition thereof with pd-l1 antibody, and application of same
EP3228615B1 (en) Dihydronaphthalene derivatives useful in the treatment of s1p5-mediated diseases
CN118005656A (zh) Kras g12c突变蛋白嘧啶并噻喃二酮类抑制剂的制备及其应用
CN114409656A (zh) Pim激酶抑制剂
AU2002354465B2 (en) Thiadiazoline derivative
CN103102352B (zh) 酪氨酸激酶抑制剂吲哚满酮衍生物
NO342001B1 (no) C-kit kinase inhibitor for anvendelse i terapeutisk behandling av gastrointestinal stromaltumor eller mastocytose.
JP2001512727A (ja) ５ｈｔ−１受容体のリガンドとしてのニ環式化合物
MX2007015678A (es) Antagonistas y agonistas de piperazina-piperidina del receptor 5-ht-1a.
CA3108046A1 (en) Benzene derivative
WO2008053863A1 (en) Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton
CN115677662A (zh) 吲唑类化合物、其制备方法及其在医药上的应用
JPWO2017183723A1 (ja) Ｋｃｎｑ２〜５チャネル活性化剤
JP7664834B2 (ja) Ｒｏｃｋキナーゼ阻害剤

Legal Events

Date Code Title Description
FZDC Discontinued application reinstated
FZDE Discontinued

Effective date: 20140424